KLF9 and central nervous system cancer: In cultured glioma cells, overexpression of KLF9 reduced viable cell numbers (Fig. 6B), elevated ROS levels (Fig. 6C), and induced intracellular cleaved-caspase3 levels (Fig. 6D).